Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 10/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 10/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 10/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 9/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 9/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 9/20 | 0.44 |
| ▸ | HDAC10 | Q969S8 | 9/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 9/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 9/20 | 0.44 |
| ▸ | HDAC9 | Q9UKV0 | 9/20 | 0.44 |
| ▸ | HDAC5 | Q9UQL6 | 9/20 | 0.44 |
| ▸ | TMIGD3 | P0DMS9 | 1/20 | 0.42 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | KAT2B | Q92831 | 2/20 | 0.38 |
| ▸ | ECE1 | P42892 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12790156 | 0.78 | RORC (0.45) | TMIGD3ADORA1HSD17B10MAPT | |
| SCHEMBL24258782 | 0.76 | TMIGD3 (0.36) | HDAC3HDAC1HDAC6HDAC4HDAC7 | |
| SCHEMBL24258815 | 0.74 | HPGD (0.39) | HPGDMAPTTSHR | |
| SCHEMBL24259060 | 0.73 | TMIGD3 (0.35) | HDAC3HDAC1HDAC6HDAC4HDAC7 | |
| SCHEMBL3048349 | 0.73 | HDAC3 (0.61) | HDAC3HDAC1HDAC6HDAC4HDAC7 | |
| SCHEMBL3045634 | 0.70 | HDAC3 (0.56) | HDAC3HDAC1HDAC6HDAC4HDAC7 | |
| SCHEMBL22904608 | 0.68 | MAPT (0.42) | TMIGD3ADORA1HPGDALOX15HSD17B10 | |
| SCHEMBL31147892 | 0.68 | HDAC3 (0.47) | HDAC3HDAC1HDAC6TMIGD3ADORA1 | |
| SCHEMBL30967773 | 0.67 | HDAC1 (0.40) | HDAC3HDAC1HDAC6HDAC4HDAC7 | |
| SCHEMBL11266906 | 0.67 | GABRA5 (0.47) | HPGDHSD17B10MAPTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11713312-B2 | Substituted bicyclic compounds as farnesoid X receptor modulators | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-08-01 | — | — | US | disclosed |
| US-20220135550-A1 | SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS | BRISTOL MYERS SQUIBB CO (US) | 2022-05-05 | — | — | US | disclosed |
| US-11254663-B2 | Substituted bicyclic compounds as farnesoid X receptor modulators | BRISTOL-MYERS SQUIBB COMPANY (US) | 2022-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220135550-A1 | SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS | FXR1, NR1H4, FXR2 | HDAC3 608/4885HDAC1 998/4885HDAC6 477/4885 |
| US-11254663-B2 | Substituted bicyclic compounds as farnesoid X receptor modulators | FXR1, NR1H4, FXR2 | HDAC3 608/4885HDAC1 998/4885HDAC6 477/4885 |
| US-11713312-B2 | Substituted bicyclic compounds as farnesoid X receptor modulators | FXR1, NR1H4, FXR2 | HDAC3 608/4885HDAC1 998/4885HDAC6 477/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.